Á. Estébanez

Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure.

E. Domingo, M. Buti, R. Macenlle, 2019, Antiviral research.

Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease

S. Llerena, J. Crespo, D. San Segundo, 2016, International Journal of Molecular Sciences.

Influence of sustained viral response on the regression of fibrosis and portal hypertension in cirrhotic HCV patients treated with antiviral triple therapy.

J. Crespo, E. Fábrega, J. Cabezas, 2017, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Lipopolysaccharide-Binding Protein Plasma Levels and Liver TNF-Alpha Gene Expression in Obese Patients: Evidence for the Potential Role of Endotoxin in the Pathogenesis of Non-Alcoholic Steatohepatitis

J. Crespo, A. Cayón, F. Pons‐Romero, 2007, Obesity surgery.

Increased bactericidal/permeability increasing protein in patients with cirrhosis

F. Pons‐Romero, Á. Estébanez, F. Casafont, 2010, Liver international : official journal of the International Association for the Study of the Liver.

Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain

R. Andrade, M. Vergara, J. Salmerón, 2019, PloS one.

Prevalence of hepatitis C in the spanish population. The prevhep study (ethon cohort)

S. Llerena, J. Calleja, M. Serra, 2017 .

Design and cost effectiveness of a hepatitis C virus elimination strategy based on an updated epidemiological study (ETHON cohort)

S. Llerena, D. Escudero-García, M. Serra, 2018 .